Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |